Priyajit Biswal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Priyajit Biswal has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Anthony Lalruatfela
RNAi Laboratory, Dept. of Life Science, National Institute of Technology Rourkela, Rourkela, Odisha 769008, India
4 shared publications - Bibekanand Mallick
RNAi and Functional Genomics Lab, Department of Life Science, National Institute of Technology Rourkela, Rourkela, India
4 shared publications - Subham Kumar Behera
RNAi Laboratory, Dept. of Life Science, National Institute of Technology Rourkela, Rourkela, Odisha 769008, India
3 shared publications - Deepak Kumar Behera
RNAi Laboratory, Dept. of Life Science, National Institute of Technology Rourkela, Rourkela, Odisha 769008, India
2 shared publications - Jiban Jyoti Dash
RNAi Laboratory, Dept. of Life Science, National Institute of Technology Rourkela, Rourkela, Odisha 769008, India
2 shared publications - Sruti Biswal
RNAi and Functional Genomics Lab, Department of Life Science, National Institute of Technology, Rourkela, Odisha, 769008, India
2 shared publications
Latest Publications
- 25 June 2026
- Published by Elsevier in Computational Biology and Chemistry
- Vol. 124 (Pt 2) , 109211
Integrated omics and virtual screening predict Tabularin as a dual inhibitor of the prognostic microRNAs mir-19a and mir-32 in colorectal cancer
- 25 June 2026
- Published by Elsevier in Computational Biology and Chemistry
- Vol. 124 (Pt 2) , 109211
Integrated omics and virtual screening predict Tabularin as a dual inhibitor of the prognostic microRNAs mir-19a and mir-32 in colorectal cancer
- 15 November 2025
- Published by Wiley in IUBMB Life
- Vol. 77 (11) , e70077
Silent Guardians Gone Rogue: The Role of PIWI and piRNA in Malignant Transformation
Malignant transformation is not merely the consequence of stochastic genetic mutations but rather a convergence of complex interplay between genetic, epigenetic, and environmental factors that collectively reprogram normal cells into cancerous ones. Central to these processes is the loss of tumor suppressor genes, activation of oncogenes, chromosomal instability, and widespread epigenetic remodeling. A pivotal aspect of this transformation involves the contribution of ncRNAs that have been recurrently implicated in malignant transformation. While much attention is directed toward miRNAs, circRNAs, and lncRNAs, piRNAs have remained comparatively overlooked in cancer biology. This is despite a growing body of evidence implicating piRNAs in regulating tumorigenic pathways, genomic stability, and epigenetic gene silencing. Our review explores the emerging role of the piRNAs and their regulatory protein PIWI in modulating key malignant features, including hyperproliferation, EMT, tumor evasion, migration, angiogenesis, and others. We also examine how this axis influences the initiation and progression of cancer, highlighting its potential to reshape established paradigms in cancer studies.
- 15 November 2025
- Published by Wiley in IUBMB Life
- Vol. 77 (11) , e70077
Silent Guardians Gone Rogue: The Role of PIWI and piRNA in Malignant Transformation
Malignant transformation is not merely the consequence of stochastic genetic mutations but rather a convergence of complex interplay between genetic, epigenetic, and environmental factors that collectively reprogram normal cells into cancerous ones. Central to these processes is the loss of tumor suppressor genes, activation of oncogenes, chromosomal instability, and widespread epigenetic remodeling. A pivotal aspect of this transformation involves the contribution of ncRNAs that have been recurrently implicated in malignant transformation. While much attention is directed toward miRNAs, circRNAs, and lncRNAs, piRNAs have remained comparatively overlooked in cancer biology. This is despite a growing body of evidence implicating piRNAs in regulating tumorigenic pathways, genomic stability, and epigenetic gene silencing. Our review explores the emerging role of the piRNAs and their regulatory protein PIWI in modulating key malignant features, including hyperproliferation, EMT, tumor evasion, migration, angiogenesis, and others. We also examine how this axis influences the initiation and progression of cancer, highlighting its potential to reshape established paradigms in cancer studies.
- 4 October 2023
- Published by Wiley in IUBMB Life
- Vol. 76 (3) , 108-124
miR‐203a—A multifaceted regulator modulating cancer hallmarks and therapy response
MicroRNAs (miRNAs) are a class of noncoding RNAs of about 19–25 nucleotides, which serve as critical modulators of various cellular and biological processes by target gene regulation. Dysregulated expression of miRNAs modulates the pathophysiology of various human diseases, including cancer. Among miRNAs, miR‐203a is one of the most extensively researched dysregulated miRNAs in different cancers. Our review investigated the roles of miR‐203a in the hallmarks of cancer modulating different pathways through target gene regulations, chemoresistance, its crosstalk with other ncRNAs or genes in terms of ceRNAs impacting oncogenesis, and its potential applications in the diagnosis, prognosis, and chemotherapeutic responses in different cancer types. miR‐203a impacts cancer cell behavior by regulating these exclusive hallmarks‐ sustaining proliferation, cell growth, invasion and metastasis, cell death, and angiogenesis. Besides, miR‐203a is found in human circulating biofluids like plasma or serum of colorectal cancer, cervical cancer, and hepatocellular carcinoma, hinting at its potential as a biomarker. Further, miR‐203a is involved in enhancing the chemosensitivity of cisplatin, docetaxel, paclitaxel, doxorubicin, and 5‐fluorouracil in a variety of malignancies through their cognate target genes. These results suggest that miR‐203a is a crucial multifaceted miRNA that controls cancer cell proliferation, metastasis, and chemotherapy response, shedding new light on its possible application.
- 4 October 2023
- Published by Wiley in IUBMB Life
- Vol. 76 (3) , 108-124
miR‐203a—A multifaceted regulator modulating cancer hallmarks and therapy response
MicroRNAs (miRNAs) are a class of noncoding RNAs of about 19–25 nucleotides, which serve as critical modulators of various cellular and biological processes by target gene regulation. Dysregulated expression of miRNAs modulates the pathophysiology of various human diseases, including cancer. Among miRNAs, miR‐203a is one of the most extensively researched dysregulated miRNAs in different cancers. Our review investigated the roles of miR‐203a in the hallmarks of cancer modulating different pathways through target gene regulations, chemoresistance, its crosstalk with other ncRNAs or genes in terms of ceRNAs impacting oncogenesis, and its potential applications in the diagnosis, prognosis, and chemotherapeutic responses in different cancer types. miR‐203a impacts cancer cell behavior by regulating these exclusive hallmarks‐ sustaining proliferation, cell growth, invasion and metastasis, cell death, and angiogenesis. Besides, miR‐203a is found in human circulating biofluids like plasma or serum of colorectal cancer, cervical cancer, and hepatocellular carcinoma, hinting at its potential as a biomarker. Further, miR‐203a is involved in enhancing the chemosensitivity of cisplatin, docetaxel, paclitaxel, doxorubicin, and 5‐fluorouracil in a variety of malignancies through their cognate target genes. These results suggest that miR‐203a is a crucial multifaceted miRNA that controls cancer cell proliferation, metastasis, and chemotherapy response, shedding new light on its possible application.
- 2 August 2022
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Vol. 1877 (5) , 188772
Emerging roles of PIWI-interacting RNAs (piRNAs) and PIWI proteins in head and neck cancer and their potential clinical implications
- 2 August 2022
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Vol. 1877 (5) , 188772
Emerging roles of PIWI-interacting RNAs (piRNAs) and PIWI proteins in head and neck cancer and their potential clinical implications